Page last updated: 2024-12-05

benzo(c)phenanthrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

benzo[c]phenanthrene : An ortho-fused polycyclic arene resulting from the symmetrical fusion of the C1-C2 bonds of two naphthalene units. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9136
CHEBI ID82292
MeSH IDM0043288

Synonyms (32)

Synonym
brn 1909296
einecs 205-896-9
3,4-benzphenanthrene
tetrahelicene
benzo(c)phenanthrene
3,4-benzophenanthrene
benzo[c]phenanthrene
195-19-7
inchi=1/c18h12/c1-3-7-16-13(5-1)9-11-15-12-10-14-6-2-4-8-17(14)18(15)16/h1-12h
tuahorsuhvukbd-uhfffaoysa-
AKOS004902356
C19197
h22xvr3v8a ,
unii-h22xvr3v8a
FT-0631863
benzo(c)phenanthrene [iarc]
3,4-benzphenanthrene [mi]
benzo-3,4-phenanthrene
CHEBI:82292
bcph
TUAHORSUHVUKBD-UHFFFAOYSA-N
DTXSID4075459
benzo[c]phenanthrene, bcr(r) certified reference material
benzo[c]phenanthrene 10 microg/ml in cyclohexane
J-012641
benzo(c)phenanthrene, vial of 25 mg, analytical standard
Q2896793
F16776
mfcd00019126
AS-57393
SY283669
CS-W012993
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
benzenoid aromatic compound
ortho-fused polycyclic arene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (44)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (29.55)18.7374
1990's12 (27.27)18.2507
2000's18 (40.91)29.6817
2010's1 (2.27)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.00 (24.57)
Research Supply Index3.83 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index83.05 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.22%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other44 (97.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]